X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (68) 68
male (50) 50
middle aged (41) 41
aged (34) 34
adult (32) 32
female (29) 29
oncology (22) 22
urinary tract infections - microbiology (19) 19
urology & nephrology (16) 16
infectious diseases (15) 15
retrospective studies (15) 15
aged, 80 and over (14) 14
index medicus (14) 14
medicine & public health (14) 14
adolescent (13) 13
internal medicine (12) 12
drug resistance, bacterial (11) 11
treatment outcome (10) 10
anti-bacterial agents - pharmacology (9) 9
japan - epidemiology (9) 9
cancer (8) 8
japan (8) 8
age factors (7) 7
child (7) 7
escherichia coli - drug effects (7) 7
gram-negative bacteria - drug effects (7) 7
microbial sensitivity tests (7) 7
prospective studies (7) 7
pseudomonas aeruginosa - drug effects (7) 7
staphylococcus aureus - drug effects (7) 7
surgical site infection (7) 7
time factors (7) 7
anti-bacterial agents - therapeutic use (6) 6
bacteria - isolation & purification (6) 6
care and treatment (6) 6
cystectomy (6) 6
enterococcus faecalis - drug effects (6) 6
escherichia coli - isolation & purification (6) 6
health aspects (6) 6
hematology, oncology and palliative medicine (6) 6
incidence (6) 6
risk factors (6) 6
surgery (6) 6
surgical wound infection - prevention & control (6) 6
analysis (5) 5
anti-bacterial agents - administration & dosage (5) 5
chemotherapy (5) 5
drug administration schedule (5) 5
enterococcus faecalis - isolation & purification (5) 5
gram-positive bacteria - drug effects (5) 5
laparoscopy (5) 5
microbiology (5) 5
pseudomonas aeruginosa - isolation & purification (5) 5
sex factors (5) 5
urologic surgical procedures (5) 5
anti-infective agents - pharmacology (4) 4
antibiotic prophylaxis (4) 4
antimicrobial agents (4) 4
bacteria - drug effects (4) 4
catheters, indwelling (4) 4
chlamydia infections - microbiology (4) 4
klebsiella - drug effects (4) 4
oncology, experimental (4) 4
penicillins - therapeutic use (4) 4
prostate (4) 4
prostatitis (4) 4
pyelonephritis (4) 4
research (4) 4
risk (4) 4
sexually transmitted diseases - epidemiology (4) 4
surgical wound infection - microbiology (4) 4
trial (4) 4
urinary bladder neoplasms - drug therapy (4) 4
urinary tract infection (4) 4
young adult (4) 4
acute disease (3) 3
antibiotic prophylaxis - methods (3) 3
antimicrobial prophylaxis (3) 3
antineoplastic combined chemotherapy protocols - adverse effects (3) 3
antineoplastic combined chemotherapy protocols - therapeutic use (3) 3
bacteriuria - microbiology (3) 3
bladder cancer (3) 3
bone neoplasms - secondary (3) 3
carcinoma, transitional cell - drug therapy (3) 3
cephalosporins - therapeutic use (3) 3
child, preschool (3) 3
chlamydia trachomatis (3) 3
chlamydia trachomatis - isolation & purification (3) 3
deoxycytidine - analogs & derivatives (3) 3
dna (3) 3
dosage forms (3) 3
fatal outcome (3) 3
gram-negative bacteria - isolation & purification (3) 3
infant (3) 3
inflammation (3) 3
kidney neoplasms - drug therapy (3) 3
kidney neoplasms - pathology (3) 3
klebsiella - isolation & purification (3) 3
medicine (3) 3
men (3) 3
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Kansenshōgaku zasshi. The Journal of the Japanese Association for Infectious Diseases, ISSN 0387-5911, 09/2015, Volume 89, Issue 5, pp. 579 - 582
Escherichia coli is the most commonly isolated bacterium in urinary tract infections, especially in acute uncomplicated cystitis. It is reported that... 
Cystitis - drug therapy | Young Adult | Anti-Bacterial Agents - therapeutic use | Acute Disease | Humans | Middle Aged | Adolescent | Aged, 80 and over | Adult | Treatment Outcome | Aged | Child
Journal Article
Cancer Science, ISSN 1347-9032, 06/2011, Volume 102, Issue 6, pp. 1171 - 1175
Journal Article
International Journal of Urology, ISSN 0919-8172, 10/2015, Volume 22, Issue 10, pp. 911 - 914
Objectives To evaluate the appearance of chemotherapy‐induced nausea and vomiting, and to compare the antiemetic efficacy of the triple combination of... 
emesis | aprepitant | urothelial cancer | palonosetron | chemotherapy‐induced nausea and vomiting | Aprepitant | Urothelial cancer | Emesis | Chemotherapy-induced nausea and vomiting | Palonosetron | PHASE-III | RANDOMIZED-TRIAL | RECEPTOR ANTAGONIST | INDUCED EMESIS | MODERATELY EMETOGENIC CHEMOTHERAPY | DOUBLE-BLIND | UROLOGY & NEPHROLOGY | HIGH-DOSE CISPLATIN | PLACEBO-CONTROLLED TRIAL | NEUROKININ-1 ANTAGONIST | ANTIEMETIC EFFICACY | chemotherapy-induced nausea and vomiting | Nausea - chemically induced | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Cisplatin - administration & dosage | Ureteral Neoplasms - drug therapy | Quinuclidines - therapeutic use | Urologic Neoplasms - drug therapy | Antiemetics - therapeutic use | Aged, 80 and over | Adult | Deoxycytidine - adverse effects | Female | Retrospective Studies | Drug Therapy, Combination | Granisetron - therapeutic use | Vomiting - prevention & control | Morpholines - therapeutic use | Deoxycytidine - administration & dosage | Serotonin Antagonists - therapeutic use | Urinary Bladder Neoplasms - drug therapy | Nausea - prevention & control | Serotonin 5-HT3 Receptor Antagonists - therapeutic use | Vomiting - chemically induced | Dexamethasone - therapeutic use | Ondansetron - therapeutic use | Carcinoma, Transitional Cell - drug therapy | Cisplatin - adverse effects | Isoquinolines - therapeutic use | Aged | Kidney Neoplasms - drug therapy | Deoxycytidine - analogs & derivatives | Prevention | Cancer patients | Care and treatment | Chemotherapy | Dexamethasone | Nausea | Cancer
Journal Article
World Journal of Urology, ISSN 0724-4983, 10/2014, Volume 32, Issue 5, pp. 1281 - 1285
Journal Article
Journal Article
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 02/2014, Volume 32, Issue 4_suppl, pp. 362 - 362
362 Background: GC combination chemotherapy of is a standard regimen for advanced UC. Although this is a highly emetogenic chemotherapy, there has been no... 
Journal Article
Urologic Oncology: Seminars and Original Investigations, ISSN 1078-1439, 06/2018, Volume 36, Issue 6, pp. 306.e9 - 306.e15
The aim of this study was to clarify the prognostic indicators for upper tract urothelial carcinoma (UTUC) following intravesical bacillus Calmette-Guérin... 
Bacillus Calmette-Guérin | Upper tract urothelial carcinoma | Nonmuscle-invasive bladder cancer | Care and treatment | Carcinoma | Research | Oncology, Experimental | Analysis | Cancer
Journal Article
Journal of Infection and Chemotherapy, ISSN 1341-321X, 2015, Volume 21, Issue 9, pp. 623 - 633
Journal Article
Japanese journal of clinical oncology, ISSN 0368-2811, 2015, Volume 45, Issue 7, pp. 682 - 687
Journal Article
Anticancer Research, ISSN 0250-7005, 10/2016, Volume 36, Issue 10, pp. 5531 - 5536
Aim: To determine prognostic factors for overall survival (OS) in renal cell carcinoma (RCC) patients with bone metastasis in the targeted-therapy era.... 
Journal Article
Journal Article
Patient Preference and Adherence, ISSN 1177-889X, 07/2016, Volume 10, pp. 1309 - 1316
Purpose: Our aim was to prospectively analyze the 3-year outcomes of naftopidil treatment for patients with benign prostatic hyperplasia (BPH), including those... 
Retreatment | Benign prostatic hyperplasia | Treatment failure | Long-term outcome | Alpha 1-blocker | Naftopidil | MEDICINE, GENERAL & INTERNAL | alpha 1-blocker | treatment failure | long-term outcome | SYMPTOMS | TAMSULOSIN | naftopidil | benign prostatic hyperplasia | retreatment | Surveys | Employee dismissals | Care and treatment | Analysis | Patient outcomes | Prostate | Hypertrophy
Journal Article